These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7891710)

  • 1. Interaction of p53 with its consensus DNA-binding site.
    Wang Y; Schwedes JF; Parks D; Mann K; Tegtmeyer P
    Mol Cell Biol; 1995 Apr; 15(4):2157-65. PubMed ID: 7891710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 oligomerization and DNA looping are linked with transcriptional activation.
    Stenger JE; Tegtmeyer P; Mayr GA; Reed M; Wang Y; Wang P; Hough PV; Mastrangelo IA
    EMBO J; 1994 Dec; 13(24):6011-20. PubMed ID: 7813439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination of DNA binding sites by mutant p53 proteins.
    Thukral SK; Lu Y; Blain GC; Harvey TS; Jacobsen VL
    Mol Cell Biol; 1995 Sep; 15(9):5196-202. PubMed ID: 7651437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How p53 binds DNA as a tetramer.
    McLure KG; Lee PW
    EMBO J; 1998 Jun; 17(12):3342-50. PubMed ID: 9628871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 domains: identification and characterization of two autonomous DNA-binding regions.
    Wang Y; Reed M; Wang P; Stenger JE; Mayr G; Anderson ME; Schwedes JF; Tegtmeyer P
    Genes Dev; 1993 Dec; 7(12B):2575-86. PubMed ID: 8276240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation.
    Reed M; Woelker B; Wang P; Wang Y; Anderson ME; Tegtmeyer P
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9455-9. PubMed ID: 7568153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two p53 tetramers bind one consensus DNA response element.
    Kearns S; Lurz R; Orlova EV; Okorokov AL
    Nucleic Acids Res; 2016 Jul; 44(13):6185-99. PubMed ID: 27034469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 domains: structure, oligomerization, and transformation.
    Wang P; Reed M; Wang Y; Mayr G; Stenger JE; Anderson ME; Schwedes JF; Tegtmeyer P
    Mol Cell Biol; 1994 Aug; 14(8):5182-91. PubMed ID: 8035799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncanonical DNA motifs as transactivation targets by wild type and mutant p53.
    Jordan JJ; Menendez D; Inga A; Noureddine M; Bell DA; Resnick MA
    PLoS Genet; 2008 Jun; 4(6):e1000104. PubMed ID: 18714371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site.
    Czerny T; Schaffner G; Busslinger M
    Genes Dev; 1993 Oct; 7(10):2048-61. PubMed ID: 8406007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-dependent acetylation of p53 by the transcription coactivator p300.
    Dornan D; Shimizu H; Perkins ND; Hupp TR
    J Biol Chem; 2003 Apr; 278(15):13431-41. PubMed ID: 12499368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Latency. C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences.
    Yakovleva T; Pramanik A; Kawasaki T; Tan-No K; Gileva I; Lindegren H; Langel U; Ekstrom TJ; Rigler R; Terenius L; Bakalkin G
    J Biol Chem; 2001 May; 276(19):15650-8. PubMed ID: 11279079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 DNA binding can be modulated by factors that alter the conformational equilibrium.
    McLure KG; Lee PW
    EMBO J; 1999 Feb; 18(3):763-70. PubMed ID: 9927436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of transactivation and transrepression function, and not RPA binding, alters growth suppression by p53.
    Leiter LM; Chen J; Marathe T; Tanaka M; Dutta A
    Oncogene; 1996 Jun; 12(12):2661-8. PubMed ID: 8700525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization.
    Nie Y; Li HH; Bula CM; Liu X
    Mol Cell Biol; 2000 Feb; 20(3):741-8. PubMed ID: 10629029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding.
    Hsu MH; Palmer CN; Song W; Griffin KJ; Johnson EF
    J Biol Chem; 1998 Oct; 273(43):27988-97. PubMed ID: 9774413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
    Bargonetti J; Manfredi JJ; Chen X; Marshak DR; Prives C
    Genes Dev; 1993 Dec; 7(12B):2565-74. PubMed ID: 8276239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding.
    Waterman JL; Shenk JL; Halazonetis TD
    EMBO J; 1995 Feb; 14(3):512-9. PubMed ID: 7859740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53.
    Kim E; Albrechtsen N; Deppert W
    Oncogene; 1997 Aug; 15(7):857-69. PubMed ID: 9266973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus.
    Jayaraman J; Prives C
    Cell; 1995 Jun; 81(7):1021-9. PubMed ID: 7600571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.